Biocon Biologics, Yoshindo launch Ustekinumab biosimilar in Japan
Ustekinumab, a monoclonal antibody, is approved for the treatment of psoriasis vulgaris and psoriatic arthritis (PsA)
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.